For a patient taking 80 U daily of Tresiba (insulin degludec) U100, how many boxes of U200 (each box contains three pens totaling 1800 U) should be ordered to cover the 30‑day supply?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tresiba U200 Ordering Calculation

Order 2 boxes of Tresiba U200 to ensure adequate 30-day supply for your patient taking 80 units daily.

Dosing Equivalence and Supply Calculation

When switching from Tresiba U100 to U200, no dose conversion is required - the patient continues taking 80 units daily 1. The U200 FlexTouch pen displays the actual number of units to be delivered, so the dose window will still show "80 units" despite the higher concentration 1.

Monthly Supply Requirements:

  • Patient's monthly need: 80 units/day × 30 days = 2,400 units
  • Each U200 box contains: 3 pens × 600 units/pen = 1,800 units per box 1
  • One box provides: 1,800 units ÷ 80 units/day = 22.5 days of therapy
  • Two boxes provide: 3,600 units ÷ 80 units/day = 45 days of therapy

Practical Ordering Recommendation

Since pharmacies typically do not break boxes and one box falls short by approximately 7-8 days, ordering 2 boxes is the appropriate choice. This provides:

  • Adequate coverage for the full 30-day period
  • A reasonable buffer for dose adjustments or missed doses
  • Compliance with standard pharmacy dispensing practices

Key Prescribing Considerations

The U200 FlexTouch pen dials in 2-unit increments (not 1-unit like U100), with a maximum single injection of 160 units 1. For your patient's 80-unit dose, this poses no limitation.

Bioequivalence Between Formulations

The U100 and U200 formulations are bioequivalent with similar pharmacokinetic and pharmacodynamic profiles 2. Research demonstrates the 90% confidence intervals for both AUC (0.99 [0.91-1.07]) and Cmax (0.93 [0.84-1.02]) fall within the 0.80-1.25 bioequivalence range, confirming these formulations can be used interchangeably 2.

Switching Protocol

For adults switching from another basal insulin, start Tresiba at the same unit dose as the previous total daily long-acting insulin 1. Your patient's 80-unit dose transfers directly without adjustment.

Common Pitfalls to Avoid

  • Never use a syringe to withdraw insulin from the FlexTouch pen - this creates significant dosing error risk 1
  • Do not attempt dose conversion - the pen displays actual units regardless of concentration 1
  • Ensure the patient understands the U200 pen clicks differently (2-unit increments) but still delivers the prescribed 80 units 1
  • Monitor blood glucose more frequently during the first few weeks after any insulin regimen change 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.